SEARCH
= Registered usersSavill P. Non-major bleeds less frequent in AF patients on apixaban. Practitioner. 2017;261 (1804): 9
Non-major bleeds less frequent in AF patients on apixaban
23 May 2017
Non-major bleeding was substantially less in patients on apixaban compared with those on warfarin in the Apixaban for Reduction in Stroke and other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
This article can be accessed only if you are a paid-up subscriber to The Practitioner.